Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2010
08/11/2010EP2216021A1 Pharmaceutical composition for treating overactive bladder
08/11/2010EP2214690A1 Melanocortin receptor binding mimetibodies, compositions, methods and uses
08/11/2010EP2214676A1 Substituted diazepan orexin receptor antagonists
08/11/2010EP1531791B1 Prevention and reduction of ischemia
08/11/2010EP1515750B1 Combinations comprising epothilones and pharmaceutical uses thereof
08/11/2010EP1499615B1 Thienyl compounds
08/11/2010EP1489170B1 Transporter selectively transporting sulfate conjugate and its gene
08/11/2010EP1438073B1 Polyoxyalkylene conjugates as enzyme inhibitors
08/11/2010CN1876833B Anti-HIV agent evaluation method
08/11/2010CN101802191A Treatment of influenza
08/11/2010CN101801979A Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
08/11/2010CN101801958A Heterocyclic amide compounds as protein kinase inhibitors
08/11/2010CN101801414A Oral and skin compositions
08/11/2010CN101801398A Cognitive disorder-ameliorating agent
08/11/2010CN101801389A Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract
08/11/2010CN101799476A Reagent box for sieving autoantibody for tsh receptor
08/11/2010CN101798317A N-substituted aminothiazole morphinan compound and preparation method and applications thereof
08/11/2010CN101798298A Imidazole derivatives
08/11/2010CN101797306A Traditional Chinese medicine for treating wet pleurisy and preparation method thereof
08/11/2010CN101185651B Application of 2,3-dihydrogen-3-hydroxymethyl-6-amino-[1,4]-benzoxazin in preparing medicine
08/10/2010US7772272 Method for enhancing glucose uptake into warm-blooded animal adipocytes
08/10/2010US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772236 Substituted pyrazoles
08/10/2010US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes
08/10/2010US7772194 Pesticidal formulations
08/10/2010US7771982 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci
08/10/2010US7771962 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle
08/10/2010US7771723 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
08/10/2010US7771711 Sphingolipids' polyalkylamines conjugates
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2487252C Esters in position 20 of camptothecins
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2477967C Purine derivatives as kinase inhibitors
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2471147C Nitric oxide donors for treatment of disease and injury
08/10/2010CA2467013C Substituted benzopyrans as selective estrogen receptor-beta agonists
08/10/2010CA2463227C Steroidal compounds for inhibiting steroid sulphotase
08/10/2010CA2462694C Neurotensin active 2,3-diaryl-pyrazolidine derivatives
08/10/2010CA2462132C 1,2,4-triazole compounds
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2450313C Process for the production of the piperidine derivative fexofenadine
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2419801C Steroid derived antibiotics
08/10/2010CA2413809C Synergistic antiplaque/antigingivitis oral composition
08/10/2010CA2395980C 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase i inhibition
08/10/2010CA2389647C Isoxazole derivatives as phosphodiesterase vii inhibitors
08/10/2010CA2361617C Uses of thank, a tnf homologue that activates apoptosis
08/10/2010CA2361238C Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/10/2010CA2253239C Antibodies against interferon alpha/beta receptor
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/10/2010CA2235627C Receptor and nucleic acid molecule encoding said receptor
08/10/2010CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
08/10/2010CA2165969C Vertebrate apoptosis gene: compositions and methods
08/10/2010CA2124583C Synthetic compounds and compositions with enhanced cell binding
08/05/2010WO2010088340A1 Oligomer-phenothiazine conjugates
08/05/2010WO2010087521A1 Combined preparation for treating joint diseases
08/05/2010WO2010087497A1 Pharmaceutical composition, and pharmaceutical preparation for treating tumors
08/05/2010WO2010087480A1 Pharmaceutical preparation or food containing peptide
08/05/2010WO2010087454A1 Quinoline derivative
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010087425A1 Prostate cancer progression inhibitor and progression inhibition method
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010087358A1 Novel composition
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087150A1 Gastric acid secretion inhibitor, and potassium channel inhibitor
08/05/2010WO2010087107A1 Melanoma metastasis inhibitor
08/05/2010WO2010086972A1 Antistress agent
08/05/2010WO2010086746A2 Compositions and methods of treating viral infections
08/05/2010US20100199368 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197813 Heterocyclic Compounds as Sweetener Enhancers
08/05/2010US20100197812 Compositions and methods for enhancing the stability of foods, beverages, nutritional supplements and cosmetics
08/05/2010US20100197808 Method for identifying mhc alleles in dogs
08/05/2010US20100197806 Method Involving 1-Benzotriazolyl Carbonate Esters of Polymers
08/05/2010US20100197784 Novel curcumin analogues and uses thereof
08/05/2010US20100197783 Radiation Protection Using Single Wall Carbon Nanotube Derivatives
08/05/2010US20100197779 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
08/05/2010US20100197772 Tissue-Specific MicroRNAs and Compositions and Uses Thereof
08/05/2010US20100197762 Antisense compounds
08/05/2010US20100197756 Indole-3-Sulphur Derivatives
08/05/2010US20100197742 New formulations and use thereof
08/05/2010US20100197736 Cetp activity inhibitors
08/05/2010US20100197728 Crystalline form of a quinolinone-carboxamide compound
08/05/2010US20100197709 Non-sedating barbiturate compounds as neuroprotective agents
08/05/2010US20100197701 Method of treating diabetes
08/05/2010US20100197647 Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
08/05/2010US20100197620 Pesticidal formulations
08/05/2010US20100197611 Alternative agent with vitamin d-like activity and an improving agent for intestinal function
08/05/2010US20100197588 Use of a peptide as a therapeutic agent
08/05/2010US20100197579 Corticotropin Releasing Factor 2 Receptor Agonists
08/05/2010US20100197563 Compositions and methods for altering elastogenesis
08/05/2010US20100196500 Anhydrous dicalcium phosphate particles and production method thereof
08/05/2010US20100196493 Method for producing stable powder compositions
08/05/2010US20100196485 Rare earth metal compounds, methods of making, and methods of using the same
08/05/2010US20100196482 Polymer-encapsulated reverse micelles
08/05/2010US20100196478 Protein matrix materials, devices and methods of making and using thereof
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 1564